Origin(SEED)
Search documents
Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer
Prnewswire· 2026-03-24 11:30
Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer Accessibility StatementSkip Navigation Appointments Reinforce Deep Technical Expertise in Biotech R&D and Capital Markets Leadership as Origin Advances Its Commercial Pipeline BEIJING, March 24, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced the app ...
Origin Agritech Launches "Aoyun 2026" New Variety Promotion Program to Drive Commercialization of Next-Generation Seed Varieties
Prnewswire· 2026-03-10 12:00
Core Insights - Origin Agritech Ltd. has launched the "Aoyun 2026" new variety promotion program aimed at accelerating the commercialization of next-generation seed varieties [1] - The program is part of a broader strategy to enhance market penetration ahead of the spring planting season in China [1] Company Initiatives - The "Aoyun 2026" program was officially launched during the 2026 Annual Marketing Executive Conference held on March 2-3, 2026, in Changsha, Hunan Province [1] - Weiwei Shi has been appointed as the General Commander of the Aoyun 2026 project, which will involve coordination among all subsidiary companies [1] - The initiative aims to provide higher value for growers through advanced seed varieties and is aligned with the company's product pipeline priorities for the 2026 selling season [1] Product Development - In fiscal year 2025, Origin Agritech launched four new corn varieties: Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728, receiving multiple national and provincial trial approvals [1] - The company is accelerating the commercialization of GMO and gene-editing technologies through a strategic alliance with China Golden-mark Biotech [1] Regional Strategy - Regional teams from various provinces presented and finalized their annual campaign plans during the conference, targeting key markets in China [1] - The deployment plan aligns with China's spring planting season, which began on March 5, 2026, after the Jingzhe solar term [1] Performance Accountability - Performance accountability contracts for fiscal years 2026 and 2027 were signed, committing management teams to specific operational and financial targets [1] - The signing of these contracts formalizes accountability structures within the company's commercial organization following a significant rebuilding year [1] Management Commentary - The CEO of Origin Agritech emphasized that the launch of "Aoyun 2026" marks a transition to aggressive commercial execution, aiming to convert core assets into shareholder value [1] - The company is focused on providing next-generation technology to growers to enhance market share in upcoming seasons [1]
Origin Agritech reports FY results (NASDAQ:SEED)
Seeking Alpha· 2026-01-30 22:21
Group 1 - The article does not provide any specific content related to company or industry analysis [1]
Origin(SEED) - 2025 Q4 - Annual Report
2026-01-30 22:01
Financial Performance - For the fiscal year ended September 30, 2023, the company reported revenues of RMB 93,307,000, which is expected to increase to RMB 113,381,000 in 2024, but projected to decline to RMB 91,290,000 in 2025, indicating a fluctuation in revenue trends [64]. - The gross profit for 2023 was RMB 17,247,000, which decreased to RMB 16,067,000 in 2024 and is projected to further decline to RMB 6,393,000 in 2025, reflecting challenges in maintaining profitability [64]. - The company incurred a net loss of RMB 57,964,000 in 2025, following a net income of RMB 62,669,000 in 2023 and RMB 18,678,000 in 2024, highlighting a significant downturn in financial performance [64]. - Total assets decreased from RMB 131,562,000 in 2024 to RMB 100,647,000 in 2025, while total liabilities also reduced from RMB 190,161,000 to RMB 162,163,000 during the same period [65]. - The company reported a current working capital deficit of RMB 84,535,000 in 2024, slightly improving to RMB 83,256,000 in 2025, indicating ongoing liquidity challenges [66]. Capital and Investment - The company has raised approximately $5.36 million (RMB 38.26 million) through the sale of shares under an "at the market" arrangement, but still requires additional capital to sustain operations [75]. - The company entered into a Cooperation Framework Agreement with BC-TID, resulting in an investment of RMB 137.7 million (US$20.2 million) for a new entity, with BC-TID owning 51% and the company owning 49% [186]. - The company has established three new seed distribution joint ventures in Xuzhou, Anhui, and Hubei, each held at 65% [189]. Market and Competition - The company faces competition from traditional seed products and international players in the GM seed market, necessitating a focus on innovation and market adaptation [72]. - The company is a leader in corn seed biotechnology in China, but faces competition from multinational corporations with greater resources and advanced technologies, which could affect product acceptance [86]. - The GM seed market outside China is dominated by major companies like Monsanto and Corteva Agriscience, which hold approximately 70% of the U.S. market, posing a threat to the company's sales and licensing opportunities [87]. - The seed business is highly competitive, with both domestic and international players, and pricing pressures from traditional seed producers may negatively impact financial results [85]. - The company faces significant challenges in obtaining necessary approvals for genetically modified (GM) corn products, which could adversely impact future development and recovery of R&D costs [78]. Regulatory Environment - Regulatory uncertainties regarding genetically modified organisms (GMOs) in China could adversely affect the company's ability to commercialize its biotech products, impacting overall business strategy [77]. - Compliance with foreign regulatory requirements is costly and may hinder the company's ability to distribute products outside China, where rigorous testing and pre-approval are mandatory [79]. - Compliance with evolving PRC regulations is critical; failure to adhere could result in fines or operational restrictions, adversely affecting revenues [101]. - The PRC government may impose penalties or require restructuring of operations if the VIE agreements are found non-compliant with regulations [145]. - The Foreign Investment Law, effective January 1, 2020, introduces uncertainties regarding the classification of VIEs and their compliance with market access requirements for foreign investment [160]. Research and Development - The company plans to continue developing new seed traits to maintain its biotech pipeline, which is crucial for future growth and competitiveness in the market [72]. - The company has developed transgenic corn seed products, including first-generation biotech products and stacked traits of Bt and glyphosate tolerance genes [182]. - The company has established several plant genetic engineering technology platforms focusing on traits such as herbicide tolerance, insect resistance, and drought stress tolerance in corn [200]. - The company has created a corn gene editing experimental platform since 2017, developing traits like high lutein and high lysine, currently under verification [209]. - The company is in the process of applying for GMO Biosafety certificates and is actively discussing requirements with relevant authorities [234]. Intellectual Property - Intellectual property rights are crucial for the company, and potential infringement claims could lead to substantial legal expenses and disrupt business operations [94]. - Intellectual property protection in China remains underdeveloped, increasing risks for the company in safeguarding its innovations [97]. - The company holds four Chinese patents and 27 trademarks related to its seed products, with additional patents pending [203]. - Hainan Aoyu and Origin Agriculture hold all intellectual property rights, managed through Exclusive Master Service Agreements and Business Cooperation Agreements [257]. Operational Risks - The company utilizes joint ventures in China for its seed business, which presents financial, managerial, and operational risks that could adversely affect revenues and cash flows [81]. - The company operates through variable interest entities (VIEs) in China, facing regulatory uncertainties that could adversely affect financial performance and enforceability of agreements [139]. - The legality and enforceability of the VIE arrangements have not been tested in court, posing risks to the company's reported ownership and financial statements [142]. - Any failure by the VIE or its shareholders to perform obligations could materially affect the company's business and financial condition [151]. - Shareholders of the VIE may have conflicts of interest that could adversely affect the company's control and economic benefits from the VIE [154]. Taxation and Financial Compliance - The applicable enterprise income tax rate for the company and its operating entities is 25% under the new EIT law [241]. - The company is subject to a 10% withholding tax on dividends payable to foreign investors from PRC sources, with no tax treaty currently existing with the British Virgin Islands [116]. - Potential adverse tax consequences may arise from transfer pricing adjustments by PRC tax authorities, impacting the company's financial condition [102]. - Changes in tax treatment for subsidiaries could increase overall tax liabilities, affecting profitability in future fiscal years [103]. Market Introduction and Approval Processes - The approval process for new seed varieties in China requires a minimum yield increase of 8% compared to control seeds, with successful candidates undergoing two growing seasons of testing in at least five locations [229]. - It typically takes a minimum of six years to bring a new seed variety to market, including three years for approval and three years for crop development [231]. - The introduction of the Corn Seed Green Pass Test System allows for faster market introduction of new hybrid varieties, with field tests conducted by the company itself [230].
Origin Agritech Announces Fiscal Year 2025 Results
Prnewswire· 2026-01-30 22:00
Core Viewpoint - Origin Agritech Ltd. reported a decline in revenue for the fiscal year 2025, primarily due to equipment upgrades and a reduction in external seed production services, while also highlighting significant partnerships and advancements in research and development [1][4][5]. Business Accomplishments and Highlights for the Year Ended September 30, 2025 - The company established a three-way partnership with China Agricultural University and the Beijing Academy of Agricultural and Forestry Sciences to enhance corn "smart plant type" improvement and innovative variety development [5]. - Origin signed cooperation agreements with 12 agricultural companies at the Sanya International Seed Industry Scientist Conference [5]. - The launch of the "Golden Harvest Club" aimed to strengthen relationships within its distribution ecosystem [5]. - Four new corn varieties were launched, with Jinqiao 8 receiving approval for introduction in five provinces [5]. Financial Results - Revenue for fiscal year 2025 was RMB 91.3 million (US$12.8 million), a decrease from RMB 113.4 million (US$16.2 million) in fiscal year 2024 [4]. - Total operating expenses increased to RMB 64.2 million (US$9.0 million) from RMB 52.7 million (US$7.5 million) in fiscal year 2024 [6]. - The net loss from continuing operations was RMB 58.0 million (US$8.2 million), compared to a net income of RMB 18.7 million (US$2.7 million) in fiscal year 2024 [7]. Liquidity and Cash Flow - As of September 30, 2025, cash and cash equivalents were approximately RMB 15.9 million (US$2.2 million), an increase from RMB 8.4 million (US$1.2 million) in the previous year [8]. - Net cash used in operating activities was RMB 22.9 million (US$3.2 million), compared to RMB 15.0 million (US$2.1 million) in fiscal year 2024 [9]. - Net cash provided by financing activities increased significantly to RMB 44.3 million (US$6.2 million) from RMB 4.5 million (US$0.6 million) in fiscal year 2024 [10]. Management Commentary - The CEO emphasized that fiscal year 2025 was a year of recovery, with a focus on restoring team capabilities and infrastructure, and outlined a three-stage strategic plan for future growth [11].
Origin Agritech Holds Annual R&D and Operations Management Conference, Establishes 2026 Strategic Priorities
Prnewswire· 2025-12-22 13:36
Core Insights - The conference held by Origin Agritech Ltd. focused on reviewing the fiscal year 2025 performance and establishing operational priorities for 2026, emphasizing the company's strategic evolution and commitment to agricultural biotechnology [1][3]. Strategic Framework and Organizational Development - The conference built on a multi-year strategic plan initiated in November 2024, aiming to enhance R&D capabilities, operational efficiency, and market expansion [2]. - The company formalized a corporate values framework that includes unified objectives, value creation, integrity, execution excellence, innovation, and long-term vision [2][3]. Research & Development Initiatives - Presentations highlighted advancements in biological breeding technology and the integration of AI into research programs, showcasing the company's commitment to leveraging cutting-edge technologies [4]. - The R&D strategy focuses on precision breeding technologies that meet market needs, combining traditional breeding expertise with AI analytics and gene editing [5]. Distinguished Academic Collaboration and Industry Expertise - The conference featured participation from leading agricultural research experts from top Chinese academic institutions, reinforcing the company's commitment to scientific innovation and strategic partnerships [6][8]. Financial Performance and Operational Excellence - The Finance Director provided a comprehensive analysis of the company's 2025 financial performance, which is crucial for strategic planning [9]. - Department leaders outlined their 2026 initiatives aimed at operational efficiency, resource optimization, and sustainable growth, emphasizing the company's focus on creating sustainable value for stakeholders [10].
Origin Agritech's Pioneering Hi3 Gene Editing Technology Awarded as Top 10 Major Progress in Chinese Agricultural Science for 2025, as Company Advances Commercialization
Prnewswire· 2025-12-02 12:00
Core Insights - Origin Agritech Ltd.'s Hi3 gene editing technology has been recognized as one of the Top 10 Major Progresses in Chinese Agricultural Science for 2025, highlighting its leadership in agricultural biotechnology and potential for enhancing crop yields and sustainability [1][2]. Group 1: Technology and Innovation - The Hi3 technology, developed in collaboration with China Agricultural University, represents a significant advancement in maize gene editing, establishing the first efficient genetic transformation system for maize induction lines [3]. - This system allows for rapid, fixed-point editing of major maize inbred lines, improving traits such as leaf angle to optimize plant architecture and enhancing maize yield at high densities within a single year, saving 3-4 years compared to traditional methods [3][4]. Group 2: Commercialization and Market Potential - Origin Agritech is actively advancing the commercialization of its gene-edited crops, with China speeding up the issuance of biosafety certificates for gene-edited crops like corn, soybeans, and wheat [4]. - The company has developed over 10 improved maize gene-editing induction lines targeting critical traits, with plans to initiate commercialization of its gene-edited corn varieties in the coming years [4]. Group 3: Management Perspective - The CEO of Origin Agritech emphasized that the recognition of the Hi3 technology validates the company's commitment to biotechnology solutions that address global food security challenges and positions the company for expanded market opportunities and enhanced crop performance [5].
Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech
Prnewswire· 2025-11-10 12:00
Core Viewpoint - Origin Agritech Ltd. has entered into a patent license agreement with Shandong Shunfeng Biotechnology Co., Ltd. for the Cas-SF01 gene editing tool, enhancing its capabilities in gene editing technologies for corn breeding [1][5][6] Group 1: Partnership and Technological Advancements - The collaboration builds on Origin Agritech's long-term relationship with China Agricultural University, focusing on key regulatory genes for corn leaf angle [2] - Using Shunfeng BioTech's Cas-SF01 platform, researchers developed edited corn induction lines, ZmRAVL1-KO1 and ZmDWF4-KO1, which optimize corn leaf angle for better yield potential [3][4] Group 2: Strategic Objectives and Commercialization - The edited induction lines aim to achieve a "smart plant architecture," improving light interception and airflow, thus allowing for higher planting density and greater yield [3][4] - Origin Agritech has initiated the biosafety assessment process for the edited lines, with an estimated timeline of 1-2 years for obtaining final biosafety certification [5] Group 3: Innovation and Future Goals - The patent license agreement is a significant step in Origin Agritech's gene editing breeding strategy, integrating research resources with innovative biotechnological tools [6] - The company is committed to advancing its gene editing innovations to contribute to agricultural technology and national food security in China [6]
Origin Agritech Obtains New Licenses for Crop Seed Production and GMO Business Operations
Prnewswire· 2025-10-24 11:00
Core Insights - Origin Agritech Ltd. is enhancing its operational capabilities and market position through strategic restructuring and new licenses aimed at long-term growth [1] Licensing and Production Capacity - Origin Agritech has obtained a new crop seed production and operation license from the Beijing Municipal Bureau of Agriculture and Rural Affairs, allowing the company to produce, process, package, wholesale, and retail corn seeds [2] - With this new license, Origin now holds two crop seed production licenses in China, expanding its regional footprint and revenue diversification [3] - The company has received formal approval to include genetically modified (GMO) crop seed production in its business scope, enabling participation in the growing GMO seed sector in China [4] Financial and Structural Developments - Origin has increased the registered capital of its subsidiary Beijing Origin Seed Ltd. from RMB 30 million (US$4.2 million) to RMB 100 million (US$14 million), providing financial flexibility for R&D and market expansion [5][6] - A strategic restructuring has consolidated key production and sales entities under Beijing Origin, establishing it as the primary operational hub to enhance efficiency and scalability [5] Market Positioning and Future Growth - These initiatives collectively strengthen Origin's capacity to serve the North China Plain agricultural region and support its mission to deliver next-generation agricultural solutions [6] - CEO Weibin Yan emphasized that the new GMO-inclusive business license, capital increase, and organizational restructuring will streamline operations and accelerate innovation, positioning the company for efficient market entry of advanced seed technologies [7]
Trump’s Market Mania: A Daily Dose of Economic Whimsy
Stock Market News· 2025-10-16 18:01
Market Performance - The Dow Jones Industrial Average (DJIA) showed resilience, initially gaining 100 points (0.2%) before closing with a modest decline of 0.1% [2] - The S&P 500 (SPX) followed a similar pattern, gaining 0.4% early on and closing up 0.2% [2] - The Nasdaq Composite (IXIC) performed best, advancing 0.7% in the morning and finishing up 0.6% for the day [2] Tariff Developments - A looming 100% tariff on Chinese goods, particularly due to rare earth export controls, caused the S&P 500 to decline by 1.8% and the Nasdaq 100 by 2.4% [3] - US Treasury Secretary announced that 85 senators are prepared to authorize tariffs of up to 500% on China for purchasing Russian oil, which could disrupt supply chains [4] - The automotive sector is facing a 100% tariff on Chinese electric vehicles, with analysts suggesting manufacturers may reroute products through Mexico [5] Agricultural Sector Impact - President Trump’s consideration to terminate business with China regarding cooking oil led to significant gains in oilseed and related agriculture stocks, with Australian Oilseeds Holdings surging over 260% [6] - Despite the tariff threats, the actual impact on cooking oil commodities is expected to be minimal due to already decreased Chinese shipments [6] Furniture Tariffs - New furniture tariffs ranging from 30% to 50% took effect on October 14th, causing shares of import-reliant retailers like RH and Wayfair to dip, while domestic manufacturers like La-Z-Boy saw modest gains [6] Inflation and Consumer Impact - President Trump declared inflation "over," while 75% of Americans report soaring prices, with tariffs costing the average household $191 per month [11] - Goldman Sachs predicts that US consumers will absorb 55% of tariff costs by year-end, potentially reaching 70% by the end of next year [11] Geopolitical Developments - Trump's announcement of a second meeting with Putin regarding the Ukraine war and India's commitment to stop Russian oil purchases added uncertainty to the market [8] - The market reacted minimally to Trump's threats of strikes on Venezuela, indicating a high tolerance for geopolitical brinkmanship [9] Cryptocurrency Ventures - Eric Trump announced a "Real Estate Tokenization Initiative," but the market for World Liberty Financial tokens has seen a decline of 39.11% over the last 90 days [10] - Bitcoin traded at $108,800, down from a Thursday high of $112,000, reflecting the volatility associated with Trump's announcements [10]